Gold Royalty Vs. Novo Nordisk AS Industry Stock Comparison

Sell

17

GROY
Gold Royalty

Last Price:

$1.18

Seasonality Move:

-0.2%

Sell

18

NONOF
Novo Nordisk AS

Last Price:

$87.53

Seasonality Move:

6.72%

Sell

17

Gold Royalty (GROY) is a Sell

Is Gold Royalty a Buy, Sell or Hold?

The current Gold Royalty [GROY] share price is $1.17. The Score for GROY is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
GROY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

18

Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

The current Novo Nordisk AS [NONOF] share price is $87.86. The Score for NONOF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

GROY Stock Price Chart

What is Gold Royalty's stock price today?

The Gold Royalty share price today is $1.17

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GROY is experiencing slight selling pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

The Novo Nordisk AS share price today is $87.86

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.

GROY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.04	Sell
Relative Strength Index (14 RSI):	34.45	Sell
Chaikin Money Flow:	-359391	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.22 - 1.3)	Sell
Bollinger Bands (100):	(1.24 - 1.42)	Sell

NONOF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.61	Sell
Relative Strength Index (14 RSI):	29.63	Sell
Chaikin Money Flow:	-16178	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(98.97 - 111.89)	Sell
Bollinger Bands (100):	(106.42 - 130.98)	Sell

GROY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.22	Sell
20-day SMA:	1.25	Sell
50-day SMA:	1.34	Sell
200-day SMA:	1.53	Sell
8-day EMA:	1.21	Sell
20-day EMA:	1.25	Sell
50-day EMA:	1.3	Sell
200-day EMA:	1.45	Sell

NONOF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	102.02	Sell
20-day SMA:	106	Sell
50-day SMA:	108.66	Sell
200-day SMA:	125.92	Sell
8-day EMA:	98.92	Sell
20-day EMA:	103.95	Sell
50-day EMA:	109.19	Sell
200-day EMA:	117.71	Sell

Gold Royalty Earnings Growth & GROY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.01 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Gold Royalty Technical Analysis

	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23
	Dec
	10	11	12	13	16	17	18	19	20	23
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23
	Dec
	10	11	12	13	16	17	18	19	20	23
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):